Posted in | News | Petrochemicals

Japan Ethyl Acetate JV Celebrates Smooth Start Up

Apr 14 2004

Related Stories

Japan Ethyl Acetate, the joint venture between Showa Denko and Kyowa Hakko Kogyo Co held a ceremony at Showa Denko’s Oita petrochemical complex to celebrate the smooth start up of the new 100,000 ton per year facility.

Ethyl acetate is a solvent that is an environmentally friendly alternative to toluene and xylene. It is used in printing and painting applications and is growing in popularity as the push for environmentally friendly alternatives and improved work conditions continues.

The joint venture was established in August 2003. Showa Denko owns 55% of the joint venture with Kyowa Hakko Kogyo owning th remaining 45%.

For more information on paints, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback